These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4630338)

  • 21. Faecal carriage of Pseudomonas aeruginosa by newborn babies.
    Cooke EM; Shooter RA; O'Farrell SM; Martin DR
    Lancet; 1970 Nov; 2(7682):1045-6. PubMed ID: 4098347
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantification of Pseudomonas aeruginosa in feces of healthy human adults.
    Sutter VL; Hurst V; Lane CW
    Health Lab Sci; 1967 Oct; 4(4):245-9. PubMed ID: 4964807
    [No Abstract]   [Full Text] [Related]  

  • 23. The evolution and spread of gentamicin-resistant Pseudomonads.
    Stone HH; Kolb LD
    J Trauma; 1971 Jul; 11(7):586-9. PubMed ID: 4997242
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of Pseudomonas aeruginosa septicemia in burns].
    Wang DW
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep; 3(3):181-3, 237-8. PubMed ID: 3151607
    [No Abstract]   [Full Text] [Related]  

  • 25. Mode of transmission of Pseudomonas aeruginosa in a burn unit and an intensive care unit in a general hospital.
    Kominos SD; Copeland CE; Grosiak B
    Appl Microbiol; 1972 Feb; 23(2):309-12. PubMed ID: 4622827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudomonas aeruginosa infection in patients with thermal lesions].
    Grishina IA; Panova IuM; Akatova NS; Smirbova NE; Minkova GL
    Klin Med (Mosk); 1978 Jul; 56(7):117-22. PubMed ID: 98664
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudomonas aeruginosa epidemic traced to delivery-room resuscitators.
    Fierer J; Taylor PM; Gezon HM
    N Engl J Med; 1967 May; 276(18):991-6. PubMed ID: 4960579
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.
    Van Rooyen CE; Ross JF; Bethune GW; MacDonald AC
    Can Med Assoc J; 1967 Nov; 97(20):1227-9. PubMed ID: 4964146
    [No Abstract]   [Full Text] [Related]  

  • 31. Source and significance of Pseudomonas aeruginosa in sputum. Patients requiring tracheal suction.
    Sutter VL; Hurst V; Grossman M; Calonje R
    JAMA; 1966 Sep; 197(11):854-8. PubMed ID: 4957763
    [No Abstract]   [Full Text] [Related]  

  • 32. Sources of Pseudomonas aeruginosa infection in burns: study of wound and rectal cultures with phage typing.
    Sutter VL; Hurst V
    Ann Surg; 1966 Apr; 163(4):597-602. PubMed ID: 4956727
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preliminary studies on the preparation of vaccine against Psudomonas aeruginosa patients with burns].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W; Zietkiewicz W
    Pol Tyg Lek; 1978 Sep; 33(39):1533-6. PubMed ID: 100771
    [No Abstract]   [Full Text] [Related]  

  • 34. Gentamicin-resistant Pseudomonas aeruginosa infection from mattresses in a burns unit.
    Fujita K; Lilly HA; Kidson A; Ayliffe GA
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):219-20. PubMed ID: 6789973
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiology of Pseudomonas aeruginosa infections in the records of the Burns Section of the Institute of Hematology].
    Serafińska D; Bukowska D; Zietkiewicz W; Nasiłowski W
    Pol Tyg Lek; 1976 Nov; 31(44):1873-5. PubMed ID: 825839
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of aeruginocine typing of PS. aeruginosa as an epidemiological marker.
    Chug TD; Sabharwal U
    Indian J Pathol Microbiol; 1978 Jul; 21(3):227-32. PubMed ID: 108218
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined use of serotyping and bacteriophage typing of Pseudomonas aeruginosa strains to broaden the epidemiological studies].
    Meitert T; Meitert E
    Arch Roum Pathol Exp Microbiol; 1966 Jun; 25(2):427-34. PubMed ID: 4964516
    [No Abstract]   [Full Text] [Related]  

  • 39. Pseudomonas aeruginosa infections in an artificial respiratory ward.
    Losonczy G; Tóth L; Petrás G; Bognár S; Lányi B; Csekes J
    Acta Microbiol Acad Sci Hung; 1971; 18(4):261-9. PubMed ID: 5006094
    [No Abstract]   [Full Text] [Related]  

  • 40. Fine-particle humidifiers. Source of Pseudomonas aeruginosa infections in a respiratory-disease unit.
    Grieble HG; Colton FR; Bird TJ; Toigo A; Griffith LG
    N Engl J Med; 1970 Mar; 282(10):531-5. PubMed ID: 4983945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.